WoS SCIE & CAS Academic Rankings
Global Journal Rankings & Directory
Explore academic hierarchies, Clarivate Impact Factors, Web of Science Q1–Q4 quartiles, and CAS divisions.
Showing 26–50 of 232 international scientific journals (Oncology)
| Rank | Journal Name & ISSN | Impact Factor | H-Index | WoS Quartile | Scopus SJR | CAS Division | Self-Citation | Docs/yr | Publisher |
|---|---|---|---|---|---|---|---|---|---|
| #26 | npj Precision Oncology ISSN: 2397-768XTop Tier | 9.9 | 59 | Q1 | 3.616Q1 | CAS Tier 1 | 2.9% | 99 | Springer Nature |
| #27 | Cancer Immunology Research ISSN: 2326-6066 / 2326-6074Top Tier | 7.9 | 157 | Q1 | 3.48Q1 | CAS Tier 1 | 2.5% | 111 | American Association for Cancer Research Inc. |
| #28 | European Journal of Cancer ISSN: 0959-8049 / 1879-0852Top Tier | 7.9 | 263 | Q1 | 2.692Q1 | CAS Tier 1 | 2.6% | 436 | Elsevier Ltd |
| #29 | British Journal of Cancer ISSN: 0007-0920 / 1532-1827Top Tier | 7.8 | 290 | Q1 | 2.803Q1 | CAS Tier 1 | 1.6% | 376 | Springer Nature |
| #30 | Jnci-Journal of the National Cancer Institute ISSN: 0027-8874 / 1460-2105Top Tier | 7.7 | 403 | Q1 | 3.786Q1 | CAS Tier 1 | 3% | 198 | Oxford University Press |
| #31 | International Journal of Oncology ISSN: 1019-6439 / 1791-2423 | 7.3 | 146 | Q1 | 1.408Q1 | CAS Tier 2 | 0% | 124 | Spandidos Publications |
| #32 | Cancer Cell International ISSN: 1475-2867Top Tier | 7 | 100 | Q1 | 1.75Q1 | CAS Tier 2 | 0% | 670 | BioMed Central |
| #33 | Molecular Cancer Therapeutics ISSN: 1535-7163 / 1538-8514Top Tier | 6.9 | 212 | Q1 | 2.392Q1 | CAS Tier 2 | 0% | 230 | American Association for Cancer Research Inc. |
| #34 | Seminars in Oncology ISSN: 0093-7754 / 1532-8708Top Tier | 6.8 | 153 | Q1 | 1.536Q1 | CAS Tier 4 | 3.3% | 33 | W.B. Saunders Ltd |
| #35 | Chinese Journal of Cancer Research ISSN: 1000-9604 / 1993-0631 | 6.7 | 51 | Q1 | 1.406Q1 | CAS Tier 1 | 14.3% | 62 | Springer Berlin Heidelberg |
| #36 | Breast Cancer Research ISSN: 1465-5411 / 1465-542X | 6.2 | 186 | Q1 | 1.907Q1 | CAS Tier 2 | 1.6% | 108 | BioMed Central |
| #37 | Oncoimmunology ISSN: 2162-4011 / 2162-402XTop Tier | 6.2 | 134 | Q1 | 2.438Q1 | CAS Tier 2 | 3.1% | 218 | Landes Bioscience |
| #38 | Oncogenesis ISSN: 2157-9024 | 6 | 78 | Q1 | 2.081Q1 | CAS Tier 2 | 1.7% | 78 | Springer Nature |
| #39 | Current Treatment Options in Oncology ISSN: 1527-2729 / 1534-6277Top Tier | 5.8 | 77 | Q1 | 1.626Q1 | CAS Tier 2 | 0% | 114 | Springer US |
| #40 | Cancer Biology & Therapy ISSN: 1538-4047 / 1555-8576 | 5.7 | 138 | Q1 | 1.407Q1 | CAS Tier 2 | 0% | 51 | Landes Bioscience |
| #41 | Clinical Epigenetics ISSN: 1868-7083 / 1868-7075Top Tier | 5.7 | 94 | Q1 | 1.787Q1 | CAS Tier 2 | 4.2% | 208 | BioMed Central |
| #42 | Cancer ISSN: 0008-543X / 1097-0142Top Tier | 5.6 | 359 | Q1 | 2.427Q1 | CAS Tier 2 | 1.6% | 435 | John Wiley and Sons Inc. |
| #43 | Jco Oncology Practice ISSN: 2688-1527 / 2688-1535 | 5.5 | 91 | Q1 | 1.985Q1 | CAS Tier 2 | 6.4% | 227 | LIPPINCOTT WILLIAMS & WILKINS |
| #44 | Current Oncology Reports ISSN: 1523-3790 / 1534-6269Top Tier | 5.2 | 91 | Q1 | 1.595Q1 | CAS Tier 2 | 0% | 139 | Springer US |
| #45 | Targeted Oncology ISSN: 1776-2596 / 1776-260X | 5.1 | 65 | Q1 | 1.435Q1 | CAS Tier 2 | 2.3% | 67 | Springer International Publishing |
| #46 | Journal of Liquid Biopsy ISSN: 2950-1954 | 5 | 9 | Q2 | 0.832Q2 | — | N/A | — | ELSEVIER |
| #47 | Cancer Science ISSN: 1347-9032 / 1349-7006Top Tier | 4.9 | 178 | Q2 | 1.509Q1 | CAS Tier 2 | 2.2% | 426 | Wiley-Blackwell |
| #48 | International Journal of Cancer ISSN: 0020-7136 / 1097-0215Top Tier | 4.9 | 275 | Q2 | 1.901Q1 | CAS Tier 2 | 1.8% | 370 | Wiley-Liss Inc. |
| #49 | Cancer Imaging ISSN: 1470-7330 | 4.8 | 73 | Q2 | 1.16Q1 | CAS Tier 2 | 2.9% | 66 | BioMed Central |
| #50 | Cancers ISSN: 2072-6694 | 4.8 | 182 | Q2 | 1.41Q1 | CAS Tier 2 | 11.1% | 6,092 | MDPI (Basel, Switzerland) |